Literature DB >> 23927873

Mammalian DNA repair: HATs and HDACs make their mark through histone acetylation.

Fade Gong1, Kyle M Miller.   

Abstract

Genetic information is recorded in specific DNA sequences that must be protected to preserve normal cellular function. Genome maintenance pathways have evolved to sense and repair DNA damage. Importantly, deleterious mutations that occur from mis-repaired lesions can lead to diseases such as cancer. As eukaryotic DNA is bound by histone proteins and organized into chromatin, the true in vivo substrate of transcription, replication and DNA repair is chromatin. Almost 50 years ago, it was found that histones contained the post-translational modification (PTM), acetylation. With the cloning and identification of transcription associated histone acetyltransferase (HAT) and histone deacetylase (HDAC) enzymes that write and erase the histone acetylation mark respectively, it was realized that this histone modification could be dynamically regulated. Chromatin is subjected to numerous PTMs that regulate chromatin structure and function, including DNA repair. As different organisms contain different histone modifications, chromatin-associated proteins and chromatin states, it is likely that chromatin-templated processes such as DNA repair will exhibit organismal differences. This article focuses on the DNA damage response (DDR) in mammalian cells and how the concerted activities of HAT and HDAC enzymes, and their histone acetylation targets, specifically participate in DNA double-strand break (DSB) repair. Defects in DNA repair and chromatin pathways are observed in cancer, and these pathways represent cancer therapeutic targets. Therefore, understanding the relationship between DNA repair and histone acetylations is important for providing mechanistic details of DSB repair within chromatin that has the potential to be exploited in the clinic.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Chromatin; DNA damage response; DNA repair; Genome stability; Histone acetylation

Mesh:

Substances:

Year:  2013        PMID: 23927873     DOI: 10.1016/j.mrfmmm.2013.07.002

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  73 in total

1.  Up-regulation of HDAC9 promotes cell proliferation through suppressing p53 transcription in osteosarcoma.

Authors:  Yu-Xin Zhao; Yi-Sheng Wang; Qi-Qing Cai; Jia-Qiang Wang; Wei-Tao Yao
Journal:  Int J Clin Exp Med       Date:  2015-07-15

Review 2.  Unravelling the genomic targets of small molecules using high-throughput sequencing.

Authors:  Raphaël Rodriguez; Kyle M Miller
Journal:  Nat Rev Genet       Date:  2014-10-14       Impact factor: 53.242

Review 3.  Systems biology: perspectives on multiscale modeling in research on endocrine-related cancers.

Authors:  Robert Clarke; John J Tyson; Ming Tan; William T Baumann; Lu Jin; Jianhua Xuan; Yue Wang
Journal:  Endocr Relat Cancer       Date:  2019-06       Impact factor: 5.678

4.  Human histone acetyltransferase 1 (Hat1) acetylates lysine 5 of histone H2A in vivo.

Authors:  Juliana I Tafrova; Stefan T Tafrov
Journal:  Mol Cell Biochem       Date:  2014-03-29       Impact factor: 3.396

Review 5.  The roles of AXIN2 in tumorigenesis and epigenetic regulation.

Authors:  Shuang Li; Chunpeng Wang; Xiaodong Liu; Shucheng Hua; Xin Liu
Journal:  Fam Cancer       Date:  2015-06       Impact factor: 2.375

Review 6.  Preserving genome integrity and function: the DNA damage response and histone modifications.

Authors:  Jae Jin Kim; Seo Yun Lee; Kyle M Miller
Journal:  Crit Rev Biochem Mol Biol       Date:  2019-06-04       Impact factor: 8.250

Review 7.  CREBBP and p300 lysine acetyl transferases in the DNA damage response.

Authors:  Ilaria Dutto; Claudia Scalera; Ennio Prosperi
Journal:  Cell Mol Life Sci       Date:  2017-11-23       Impact factor: 9.261

8.  Lysine-specific post-translational modifications of proteins in the life cycle of viruses.

Authors:  Anna P Loboda; Surinder M Soond; Mauro Piacentini; Nickolai A Barlev
Journal:  Cell Cycle       Date:  2019-07-10       Impact factor: 4.534

9.  Double duty: ZMYND8 in the DNA damage response and cancer.

Authors:  Fade Gong; Kyle M Miller
Journal:  Cell Cycle       Date:  2018-03-19       Impact factor: 4.534

10.  HDAC2 overexpression correlates with aggressive clinicopathological features and DNA-damage response pathway of breast cancer.

Authors:  Wenqi Shan; Yuanyuan Jiang; Huimei Yu; Qianhui Huang; Lanxin Liu; Xuhui Guo; Lei Li; Qingsheng Mi; Kezhong Zhang; Zengquan Yang
Journal:  Am J Cancer Res       Date:  2017-05-01       Impact factor: 6.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.